FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/11/022040 [Registered on: 18/11/2019] Trial Registered Prospectively
Last Modified On: 14/11/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Management of Blood Pressure by Trivrit and Aragvadha Churna as daily mild laxative 
Scientific Title of Study   "Study the effect of Nitya Virechana with Trivrit and Aragvadha Churna in the management of Stage 1 Essential Hypertension" 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Manju Mohan 
Designation  PG Scholar 
Affiliation  Datta Meghe Institute of Medical Sciences (Deemed University) 
Address  Department of Panchakarma Mahatma Gandhi Ayurveda College Hospital and Research Centre Salod(H), Wardha.

Wardha
MAHARASHTRA
442001
India 
Phone  831994245  
Fax    
Email  manjumohan13@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Punam Sawarkar 
Designation  Associate Professor 
Affiliation  Datta Meghe Institute of Medical Sciences (Deemed University) 
Address  Department of Panchakarma Mahatma Gandhi Ayurveda College Hospital and Research Centre Salod(H), Wardha

Wardha
MAHARASHTRA
442001
India 
Phone  9860667023  
Fax    
Email  drsuple.punam@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Punam Sawarkar 
Designation  Associate Professor 
Affiliation  Datta Meghe Institute of Medical Sciences (Deemed University) 
Address  Department of Panchakarma Mahatma Gandhi Ayurveda College Hospital and Research Centre Salod(H), Wardha

Wardha
MAHARASHTRA
442001
India 
Phone  9860667023  
Fax    
Email  drsuple.punam@gmail.com  
 
Source of Monetary or Material Support  
Department of Panchakarma, Mahatma Gandhi Ayurveda College Hospital and Research Centre, Salod(H), Wardha 
 
Primary Sponsor  
Name  Dr Manju Mohan 
Address  Department of Panchakarma, Mahatma Gandhi Ayurveda College Hospital and Research Centre, Salod (H), Wardha 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Manju Mohan  Mahatma Gandhi Ayurved College Hospital and Research Center Salod (H) Wardha  Department of Panchakarama OPD no. 40 Wardha
Wardha
MAHARASHTRA 
831994245

manjumohan13@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Datta Meghe Institute of Medical Sciences  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I10||Essential (primary) hypertension,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Group-A Trivrit Churna (Operculina terpethum Linn.)  Group-A Trivrit Churna Nitya Virechana Route - Oral Route Study Duration - 30 days Frequency -10 gms of Trivrit Churna daily for 15 days at bedtime with lukewarm water 
Intervention  Group-B Aragvadha Churna (Cassia fistula Linn.)  Group-B Aragvadha Churna Nitya Virechana Route - Oral Route Study Duration - 30 days Frequency -10 gms of Aragvadha Phalamajja Churna daily for 15 days at bedtime with lukewarm water 
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Patients of either sex between the age group of 30-60 yrs will be selected.
2. Newly detected cases of Stage 1 Essential Hypertension will be selected.
3. Hypertension stage 1-SBP (130-139) or DBP (80-89) will be included for the study.
 
 
ExclusionCriteria 
Details  1. Hypertension associated with:
a. Cardio-vascular diseases
b. Cerebro-vascular diseases
c. Hypothyroidism
d. Diabetes Mellitus (Type 1/ Type 2/ GDM)
e. Pregnant and lactating women
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Reduce in the symptoms and range of Blood pressure  Six months 
 
Secondary Outcome  
Outcome  TimePoints 
1. To study the effect of Nitya Virechana with Trivrit Churna on Systolic and Diastolic blood pressure.
2. To study the effect of Nitya Virechana with Aragvadha Churna on Systolic and Diastolic blood pressure.
3. To compare the effect of Nitya Virechana with Trivrit and Aragvadha Churna on Systolic and Diastolic blood pressure.
 
Six months 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   21/11/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  
Patients will be recruited from inclusion criteria and study the effect of  Trivrit and Aragvadha Churna Nitya virechana in Stage 1 Essential Hypertension
To study the effect of Nitya virechana with Trivrit Churna on systolic and diastolic blood pressure.
To study the effect of Nitya virechana with Aragvadha Churna on systolic and diastolic blood pressure
To compare the effect of Nitya virechana with Trivrit and Aragvadha churna on systolic and diastolic blood pressure.



 
Close